Unknown

Dataset Information

Pharmacokinetics and tolerability of lefamulin following intravenous and oral dosing.


ABSTRACT:

Objectives

To explore the pharmacokinetics (PK) of oral and intravenous (iv) lefamulin after single and multiple doses, and the effect of food on bioavailability.

Methods

Lefamulin PK was examined in four studies. In Study 1, PK was assessed in patients with acute bacterial skin and skin structure infections who received repeated iv lefamulin q12h (150 mg). In Study 2, a four-period crossover study, healthy subjects received a single dose of oral lefamulin [immediate-release (IR) tablet, 1 × 600 mg] in a fasted and fed state, oral lefamulin (capsule, 3 × 200 mg) in a fasted state, and iv lefamulin in a fasted state. In Study 3, a three-period crossover study, healthy males received a single oral lefamulin dose (IR) in the following states: fasted, fasted followed by a high-c

SUBMITTER: Wicha WW 

PROVIDER: S-EPMC6449572 | biostudies-literature | 2019 Apr

REPOSITORIES: biostudies-literature